Autoantibody Profile in Systemic Sclerosis

Systemic sclerosis is a generalized disorder of connective tissue clinically characterized by thickening and fibrosis of the skin and by distinctive forms of involvement of internal organs. One of the hallmarks of systemic sclerosis is the presence of serum autoantibodies against a variety of nuclea...

Full description

Bibliographic Details
Main Authors: Marvin J Fritzler, Mohammad Khajedaluee, Reza Amin, Fatemeh Behmanesh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2010-02-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15158.pdf&manuscript_id=15158
_version_ 1818301519014920192
author Marvin J Fritzler
Mohammad Khajedaluee
Reza Amin
Fatemeh Behmanesh
author_facet Marvin J Fritzler
Mohammad Khajedaluee
Reza Amin
Fatemeh Behmanesh
author_sort Marvin J Fritzler
collection DOAJ
description Systemic sclerosis is a generalized disorder of connective tissue clinically characterized by thickening and fibrosis of the skin and by distinctive forms of involvement of internal organs. One of the hallmarks of systemic sclerosis is the presence of serum autoantibodies against a variety of nuclear and cytoplasmic antigens. The primary purpose of this study was to identify the autoantibodies profile in the scleroderma sera and the secondary goal was to determine the correlation and discrepancy of autoantibody profile. Autoantibody profile was determined in 118 samples stored in the Advanced Diagnostic Laboratory at the University of Calgary. 78 sera were provided from Canadian and 40 sera were provided from Ukraine. We used the following techniques to identify autoantibodies profile in scleroderma patients: 1. Antinuclear antibody (ANA) by indirect immunofluorescence on human epithelial cell substrate 2. Detection and identification of specific autoantibodies by Innolia strip assay 3. Detection and identification of specific autoantibodies against extractable nuclear antigens. 111 out of 118 patients showed positive ANA results by indirect immunofluorescence and 7 patients had negative ANA results. Anti-ENA analyses by Inolia were positive in 84 patients, while by western blotting 81 patients showed positive results. In this study, we compared the results of anti-ENA antibody by Innolia with SLR technique. A significant correlation was found between anti-SCl-70 antibodies (P=0.000) and anti- RNP antibodies (P=0.001) and JO-1 antibodies (P=0.014). Thus, we may propose that SLR and Innolia techniques could be used for the detection of autoantibody in systemic sclerosis.
first_indexed 2024-12-13T05:24:18Z
format Article
id doaj.art-44d59978ba6342ea9f323ac2b6a123be
institution Directory Open Access Journal
issn 0044-6025
0173-5969
language English
last_indexed 2024-12-13T05:24:18Z
publishDate 2010-02-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-44d59978ba6342ea9f323ac2b6a123be2022-12-21T23:58:15ZengTehran University of Medical SciencesActa Medica Iranica0044-60250173-59692010-02-014811220Autoantibody Profile in Systemic SclerosisMarvin J FritzlerMohammad KhajedalueeReza AminFatemeh BehmaneshSystemic sclerosis is a generalized disorder of connective tissue clinically characterized by thickening and fibrosis of the skin and by distinctive forms of involvement of internal organs. One of the hallmarks of systemic sclerosis is the presence of serum autoantibodies against a variety of nuclear and cytoplasmic antigens. The primary purpose of this study was to identify the autoantibodies profile in the scleroderma sera and the secondary goal was to determine the correlation and discrepancy of autoantibody profile. Autoantibody profile was determined in 118 samples stored in the Advanced Diagnostic Laboratory at the University of Calgary. 78 sera were provided from Canadian and 40 sera were provided from Ukraine. We used the following techniques to identify autoantibodies profile in scleroderma patients: 1. Antinuclear antibody (ANA) by indirect immunofluorescence on human epithelial cell substrate 2. Detection and identification of specific autoantibodies by Innolia strip assay 3. Detection and identification of specific autoantibodies against extractable nuclear antigens. 111 out of 118 patients showed positive ANA results by indirect immunofluorescence and 7 patients had negative ANA results. Anti-ENA analyses by Inolia were positive in 84 patients, while by western blotting 81 patients showed positive results. In this study, we compared the results of anti-ENA antibody by Innolia with SLR technique. A significant correlation was found between anti-SCl-70 antibodies (P=0.000) and anti- RNP antibodies (P=0.001) and JO-1 antibodies (P=0.014). Thus, we may propose that SLR and Innolia techniques could be used for the detection of autoantibody in systemic sclerosis.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15158.pdf&manuscript_id=15158Autoantibodiessclerodermasystemicnuclear antigens
spellingShingle Marvin J Fritzler
Mohammad Khajedaluee
Reza Amin
Fatemeh Behmanesh
Autoantibody Profile in Systemic Sclerosis
Acta Medica Iranica
Autoantibodies
scleroderma
systemic
nuclear antigens
title Autoantibody Profile in Systemic Sclerosis
title_full Autoantibody Profile in Systemic Sclerosis
title_fullStr Autoantibody Profile in Systemic Sclerosis
title_full_unstemmed Autoantibody Profile in Systemic Sclerosis
title_short Autoantibody Profile in Systemic Sclerosis
title_sort autoantibody profile in systemic sclerosis
topic Autoantibodies
scleroderma
systemic
nuclear antigens
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/15158.pdf&manuscript_id=15158
work_keys_str_mv AT marvinjfritzler autoantibodyprofileinsystemicsclerosis
AT mohammadkhajedaluee autoantibodyprofileinsystemicsclerosis
AT rezaamin autoantibodyprofileinsystemicsclerosis
AT fatemehbehmanesh autoantibodyprofileinsystemicsclerosis